Endothelial activation and stress index for prediction of mortality in asthma.

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2025-07-09 eCollection Date: 2025-01-01 DOI:10.3389/fmed.2025.1622944
Yili He, Yang Li, Yuan Xiaojin, Dan Wu, Wenyan Jiang, Xianlong Xie
{"title":"Endothelial activation and stress index for prediction of mortality in asthma.","authors":"Yili He, Yang Li, Yuan Xiaojin, Dan Wu, Wenyan Jiang, Xianlong Xie","doi":"10.3389/fmed.2025.1622944","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>EASIX (Endothelial Activation and Stress Index) has been shown to be associated with the prognosis of various diseases in numerous studies, but its relationship with short- and medium-term outcomes in asthma patients admitted to the ICU (Intensive Care Unit) remains unclear.</p><p><strong>Methods: </strong>This retrospective cohort study included 3,737 asthma patients from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database (2008-2019). We calculated log2(EASIX) using platelet count, creatinine, and lactate dehydrogenase levels measured on ICU admission day 1. We analyzed the association between log2(EASIX) and 28-day and 60-day in-hospital mortality using multivariable Cox regression and restricted cubic splines. Proportional hazards assumptions were tested to ensure no time-dependent bias. Subgroup analyses and interaction tests were conducted to verify the stability. ROC (Receiver Operating Characteristic) analysis was performed to assess the prognostic performance of log2(EASIX).</p><p><strong>Results: </strong>The mean age of patients was 62.5 years, with 289 deaths at 28 days and 432 at 60 days. Higher log2(EASIX) was independently associated with increased mortality at both 28 days [hazard ratio (HR) = 1.14, 95% confidence interval (CI): 1.02-1.27, <i>p</i> = 0.017] and 60 days (HR = 1.13, 95% CI: 1.02-1.24, <i>p</i> = 0.017). The highest tertile had significantly higher mortality than the lowest tertile (28-day: HR = 1.84, 95% CI: 1.16- 2.90, <i>p</i> = 0.009; 60-day: HR = 1.65, 95% CI: 1.08-2.51, <i>p</i> = 0.019). A linear relationship was observed between log2(EASIX) and both 28-day and 60-day mortality (P for non-linearity test = 0.29 and 0.633). Subgroup analyses and interaction tests indicated that the association between log2(EASIX) and mortality was stable. The ROC curve analysis revealed AUC (Area Under the Curve) values for 28- and 60-day mortality of 0.892 and 0.881, respectively, with Youden indices of 0.63 and 0.61, indicating good predictive performance.</p><p><strong>Conclusion: </strong>Elevated log2(EASIX) levels are independently associated with increased in-hospital mortality in patients with asthma. Endothelial Activation and Stress Index show good predictive performance for short- and medium-term mortality in this patient population.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1622944"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12283289/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1622944","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: EASIX (Endothelial Activation and Stress Index) has been shown to be associated with the prognosis of various diseases in numerous studies, but its relationship with short- and medium-term outcomes in asthma patients admitted to the ICU (Intensive Care Unit) remains unclear.

Methods: This retrospective cohort study included 3,737 asthma patients from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database (2008-2019). We calculated log2(EASIX) using platelet count, creatinine, and lactate dehydrogenase levels measured on ICU admission day 1. We analyzed the association between log2(EASIX) and 28-day and 60-day in-hospital mortality using multivariable Cox regression and restricted cubic splines. Proportional hazards assumptions were tested to ensure no time-dependent bias. Subgroup analyses and interaction tests were conducted to verify the stability. ROC (Receiver Operating Characteristic) analysis was performed to assess the prognostic performance of log2(EASIX).

Results: The mean age of patients was 62.5 years, with 289 deaths at 28 days and 432 at 60 days. Higher log2(EASIX) was independently associated with increased mortality at both 28 days [hazard ratio (HR) = 1.14, 95% confidence interval (CI): 1.02-1.27, p = 0.017] and 60 days (HR = 1.13, 95% CI: 1.02-1.24, p = 0.017). The highest tertile had significantly higher mortality than the lowest tertile (28-day: HR = 1.84, 95% CI: 1.16- 2.90, p = 0.009; 60-day: HR = 1.65, 95% CI: 1.08-2.51, p = 0.019). A linear relationship was observed between log2(EASIX) and both 28-day and 60-day mortality (P for non-linearity test = 0.29 and 0.633). Subgroup analyses and interaction tests indicated that the association between log2(EASIX) and mortality was stable. The ROC curve analysis revealed AUC (Area Under the Curve) values for 28- and 60-day mortality of 0.892 and 0.881, respectively, with Youden indices of 0.63 and 0.61, indicating good predictive performance.

Conclusion: Elevated log2(EASIX) levels are independently associated with increased in-hospital mortality in patients with asthma. Endothelial Activation and Stress Index show good predictive performance for short- and medium-term mortality in this patient population.

内皮细胞激活和应激指数预测哮喘患者死亡率。
背景:EASIX(内皮激活和应激指数)已在众多研究中被证明与多种疾病的预后相关,但其与ICU(重症监护病房)哮喘患者中短期预后的关系尚不清楚。方法:本回顾性队列研究纳入重症监护医疗信息市场- iv (MIMIC-IV)数据库(2008-2019)中的3737例哮喘患者。我们使用在ICU入院第1天测量的血小板计数、肌酐和乳酸脱氢酶水平计算log2(EASIX)。我们使用多变量Cox回归和受限三次样条分析了log2(EASIX)与住院28天和60天死亡率之间的关系。对比例风险假设进行了检验,以确保没有时间相关的偏差。通过亚组分析和相互作用试验验证了稳定性。采用ROC (Receiver Operating Characteristic)分析评估log2(EASIX)对预后的影响。结果:患者平均年龄为62.5岁,28天死亡289例,60天死亡432例。较高的log2(EASIX)与28天和60天的死亡率增加独立相关[风险比(HR) = 1.14, 95%可信区间(CI): 1.02-1.27, p = 0.017]。最高孢子的死亡率显著高于最低孢子(28天:HR = 1.84, 95% CI: 1.16 ~ 2.90, p = 0.009;60天:HR = 1.65, 95%置信区间CI: 1.08 - -2.51, p = 0.019)。log2(EASIX)与28天和60天死亡率均呈线性关系(非线性检验P = 0.29和0.633)。亚组分析和相互作用试验表明,log2(EASIX)与死亡率之间的关联是稳定的。ROC曲线分析显示,28天死亡率和60天死亡率的AUC值分别为0.892和0.881,约登指数分别为0.63和0.61,具有较好的预测效果。结论:升高的log2(EASIX)水平与哮喘患者住院死亡率升高独立相关。内皮细胞激活和应激指数对该患者群体的中短期死亡率具有良好的预测性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信